Fischer Medical Ventures Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹107 Cr +24.5% YoYSee revenue, profit and what management said. You are viewing Q2 FY25.
FM

Fischer Medical Ventures Ltd

Q2 FY25Healthcare Equipment & Supplies

Fischer Medical Ventures Q2 FY25 earnings call: Revenue & Margins

Q2 FY25 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹40Cr
+291.9% QoQ
Net profit
₹0Cr
Turned profitable QoQ
Margin
1.26%
+3.3 pp QoQ

Based on Fischer Medical Ventures Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹34
Market cap₹2.3K Cr
P/E94.6

The short version

The investor presentation reports the following for the quarter: - EBITDA: ₹36.3 crore, a 45.5% year-on-year increase.

From Fischer Medical Ventures Ltd's Q2 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

See what Fischer Medical Ventures Ltd said on revenue & sales performance — free account, 30 seconds.

Profitability & Margins

See what Fischer Medical Ventures Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Established manufacturing presence in India in 2022 at Andhra Pradesh Medtech Zone (AMTZ), described as the first and only accredited "Made in India" MRI facility (Page 3, 9).
  • Strong sales pipeline of over 100 MRI units across India, MENA, and SEA regions (Page 9).
  • Deployment of E-Health Access Points (eHAPs) and kiosks planned at 33,000 schools across India, with a full rollout expected over the next 3-5 years (Page 18).

2 more points from Fischer Medical Ventures Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1OSEL Devices
Rev 1Mar 3
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Fischer Medical Ventures Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The presentation mentions a "Strong Sales Pipeline of >100 Units of MRIs across India, MENA and SEA" (Page 9), indicating robust order inflow or pending orders.
  • It refers to "Strong order books and expansion into new geographies and product lines" targeted for 2025 (Page 3).

Fischer Medical Ventures Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Fischer Medical Ventures Ltd Q2 FY25 results — key figures

Fischer Medical Ventures Ltd Q2 FY25 reported results vs year-ago quarter, ₹ crore
₹ CrQ2 FY25Q1 FY25QoQ
Revenue4010+291.9%
Operating profit (EBITDA)1-0—
Operating margin1.26%-2.08%+3.3 pp
Profit before tax00+200%
Net profit (PAT)0-0—
EPS (₹)0.010.00—

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹107 Cr, net profit ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Fischer Medical Ventures Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Fischer Medical Ventures Ltd Q2 FY25 results?

The investor presentation reports the following for the quarter: - EBITDA: ₹36.3 crore, a 45.5% year-on-year increase.

What is Fischer Medical Ventures Ltd share price analysis?

Fischer Medical Ventures Ltd currently shows a neutral. The stock trades at a P/E of 94.6 with a market cap of ₹2,316 Cr. Investors should review the full earnings analysis for detailed insights.

Is Fischer Medical Ventures Ltd planning capital expenditure?

Established manufacturing presence in India in 2022 at Andhra Pradesh Medtech Zone (AMTZ), described as the first and only accredited "Made in India" MRI facility (Page 3, 9).

Keep Fischer Medical Ventures Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.